Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
294.11
-4.20 (-1.41%)
Mar 23, 2026, 4:00 PM EDT - Market closed

PRAX Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
-8.552.45--
Revenue Growth (YoY)
-249.53%---
Gross Profit
-8.552.45--
Selling, General & Admin
59.0856.3142.0559.9547.08
Research & Development
267.12152.4186.77155.04120.26
Total Operating Expenses
326.2208.72128.82214.99167.33
Operating Income
-326.2-200.17-126.37-214.99-167.33
Total Non-Operating Income (Expense)
22.9317.353.10.960.27
Pretax Income
-303.27-182.82-123.28-214.03-167.06
Net Income
-303.27-182.82-123.28-214.03-167.06
Net Income to Common
-303.27-182.82-123.28-214.03-167.06
Shares Outstanding (Basic)
2318733
Shares Outstanding (Diluted)
2318733
Shares Change (YoY)
25.68%171.55%114.58%8.58%374.34%
EPS (Basic)
-13.48-10.21-18.69-69.65-59.10
EPS (Diluted)
-13.48-10.21-18.69-69.65-59.10
Free Cash Flow
-249.12-131.76-111.19-185.49-125.6
Free Cash Flow Per Share
-11.07-7.36-16.86-60.36-44.38
Gross Margin
-100.00%100.00%--
Operating Margin
--2340.29%-5164.41%--
Profit Margin
--2137.48%-5037.88%--
FCF Margin
--1540.48%-4543.77%--
EBITDA
-326.06-199.81-125.94-214.57-167.15
EBITDA Margin
--2336.10%-5146.75%--
EBIT
-326.2-200.17-126.37-214.99-167.33
EBIT Margin
--2340.29%-5164.41%--
Updated Feb 19, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q